HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ergotism with acute limb ischemia, provoked by HIV protease inhibitors interaction with ergotamine, rescued by multisite transluminal balloon angioplasty.

Abstract
Acute limb ischemia induced by arterial vasospasm remains an exceptional situation, favoured by the use of arterial vasoconstrictors. The risk of these substances is largely underestimated in the general population, especially with the co-administration of strong cytochrome inhibitors like human immunodeficiency virus (HIV) protease inhibitors. A 33-year-old woman, who used to take dihydroergotamine for orthostatic hypotension, was prescribed a post-exposure HIV prophylaxis including lopinavir and ritonavir. One day later, she presented an acute bilateral limb ischemia with a sudden pain in both calves, initially while walking and then at rest with bilateral ischemic toes. Angiography confirmed diffuse arterial vasospasm of the lower limb arteries. A first-line therapy with isosorbide dinitrate and amlodipine was ineffective, with rapid clinical worsening. A combination of intra-arterial injections and intra-venous infusions of vasodilators, transluminal balloon angioplasty and bilateral 4-Compartment fasciotomies permitted rapid improvement and finally resulted in both lower limbs rescue. This case and literature review illustrate ergotism due to ergotamine overdose after taking HIV protease inhibitors. It also demonstrates the benefit of an interventional procedure besides medical therapy with vasodilators in severe arterial vasospasm. All along the lower limb arterial tree, transluminal balloon angioplasty restored the blood flow, without vasospasm recurrence. CONCLUSION: In case of ergotism with acute lower limbs ischemia, combining medical vasodilator therapy with interventional procedure can restore the arterial blood flow, thus allowing to save lower limbs.
AuthorsN Mohamedi, T Mirault, A Durivage, M Di Primio, L Khider, G Detriche, S El Batti, M Sapoval, E Messas, G Goudot
JournalJournal de medecine vasculaire (J Med Vasc) Vol. 46 Issue 1 Pg. 13-21 (Feb 2021) ISSN: 2542-4513 [Print] France
PMID33546816 (Publication Type: Case Reports, Journal Article, Review)
CopyrightCopyright © 2020 Elsevier Masson SAS. All rights reserved.
Chemical References
  • HIV Protease Inhibitors
  • Vasoconstrictor Agents
  • Dihydroergotamine
Topics
  • Acute Disease
  • Adult
  • Angioplasty, Balloon
  • Dihydroergotamine (adverse effects)
  • Ergotism (diagnosis, etiology, physiopathology)
  • Female
  • HIV Infections (prevention & control)
  • HIV Protease Inhibitors (adverse effects)
  • Humans
  • Ischemia (chemically induced, diagnostic imaging, physiopathology, therapy)
  • Lower Extremity (blood supply)
  • Risk Factors
  • Treatment Outcome
  • Vasoconstrictor Agents (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: